Genmab A/S has published its Articles of Association dated October 16, 2012. The Articles of Association can be found on Genmab’s website: http://ir.genmab.com/releases.cfm.
Contact:
Rachel Curtis Gravesen, Senior Vice President, Investor Relations & Communications
T: +45 33 44 77 20; M: +45 25 12 62 60; E: r.gravesen@genmab.com
Genmab A/S
Bredgade 34E
1260 Copenhagen K
Denmark
www.genmab.com
CVR no. 2102 3884
Company Announcement Net sales of DARZALEX® in the second quarter of 2026 totaled USD 4,207 millionGenmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity...
Read MoreMedia ReleaseCOPENHAGEN, Denmark; July 6, 2026 TEPKINLY® (epcoritamab) plus lenalidomide and rituximab (R2) is the first and only bispecific-based therapy approved in Europe for the treatment of...
Read More